Browsing by Author "Rejeski, Kai"
Now showing items 1-7 of 7
-
Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
Blumenberg, Viktoria; Iacoboni García-Calvo, Gloria; Kharboutli, Soraya; Hernani, Rafael; Barba Suñol, Pere; Lopez Corral, Lucia; Rejeski, Kai (Wolters Kluwer Health, 2023-04) -
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Perez, Ariel; Jurinovic, Vindi; Holtick, Udo; Rejeski, Kai; IACOBONI, GLORIA; Bücklein, Veit (Wolters Kluwer Health, 2023-07-11) -
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
IACOBONI, GLORIA; Rejeski, Kai; Villacampa Javierre, Guillermo; van Doesum, Jaap; CHIAPPELLA, ANNALISA; Bonifazi, Francesca; Camacho-Arteaga, Lina ; Marin Niebla, Ana; Barba, Pere (American Society of Hematology, 2022-06-28) -
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Burchert, Andreas; SESQUES, Pierre; Fransecky, Lars; Rejeski, Kai; IACOBONI, GLORIA; Barba, Pere; Bücklein, Veit (American Society of Hematology, 2022-08-23) -
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
Perez, Ariel; Blumenberg , Viktoria; Bücklein, Veit; Völkl, Simon; Rejeski, Kai; IACOBONI, GLORIA; Barba, Pere (American Association for the Advancement of Science, 2023-09-22) -
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Perez, Ariel; Iacoboni García-Calvo, Gloria; Penack, Olaf; Jentzsch, Liv; Carpio Segura, Cecilia Carmen; Barba Suñol, Pere; Rejeski, Kai; Bücklein, Veit (BMJ, 2022-05) -
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
Wang, Yucai; albanyan, omar; Munoz, Javier; Rejeski, Kai; SESQUES, Pierre; IACOBONI, GLORIA; Barba, Pere (Wiley, 2023-11)